Software - Infrastructure
Compare Stocks
2 / 10Stock Comparison
SANG vs LPSN
Revenue, margins, valuation, and 5-year total return — side by side.
Software - Application
SANG vs LPSN — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Software - Infrastructure | Software - Application |
| Market Cap | $139M | $32M |
| Revenue (TTM) | $307M | $244M |
| Net Income (TTM) | $-8M | $-67M |
| Gross Margin | 52.8% | 62.2% |
| Operating Margin | -1.3% | -9.6% |
| Total Debt | $56M | $392M |
| Cash & Equiv. | $13M | $95M |
SANG vs LPSN — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Sangoma Technologie… (SANG) | 100 | 291.0 | +191.0% |
| LivePerson, Inc. (LPSN) | 100 | 0.5 | -99.5% |
Price return only. Dividends and distributions are not included.
Quick Verdict: SANG vs LPSN
Each card shows where this stock fits in a portfolio — not just who wins on paper.
SANG carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 4 yrs, beta 0.16
- Rev growth -0.9%, EPS growth 40.5%, 3Y rev CAGR 5.3%
- 20.0% 10Y total return vs LPSN's -97.0%
In this particular matchup, LPSN is outpaced on most metrics by others in the set.
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | -0.9% revenue growth vs LPSN's -22.0% | |
| Quality / Margins | -2.5% margin vs LPSN's -27.6% | |
| Stability / Safety | Beta 0.16 vs LPSN's 2.05 | |
| Dividends | Tie | Neither stock pays a meaningful dividend |
| Momentum (1Y) | -27.5% vs LPSN's -77.1% | |
| Efficiency (ROA) | -2.2% ROA vs LPSN's -12.4%, ROIC -0.4% vs -6.6% |
SANG vs LPSN — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
SANG vs LPSN — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
SANG leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
SANG and LPSN operate at a comparable scale, with $307M and $244M in trailing revenue. SANG is the more profitable business, keeping -2.5% of every revenue dollar as net income compared to LPSN's -27.6%. On growth, SANG holds the edge at -13.2% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $307M | $244M |
| EBITDAEarnings before interest/tax | $57M | -$562,000 |
| Net IncomeAfter-tax profit | -$8M | -$67M |
| Free Cash FlowCash after capex | $43M | -$43M |
| Gross MarginGross profit ÷ Revenue | +52.8% | +62.2% |
| Operating MarginEBIT ÷ Revenue | -1.3% | -9.6% |
| Net MarginNet income ÷ Revenue | -2.5% | -27.6% |
| FCF MarginFCF ÷ Revenue | +14.0% | -17.4% |
| Rev. Growth (YoY)Latest quarter vs prior year | -13.2% | -19.0% |
| EPS Growth (YoY)Latest quarter vs prior year | -6.7% | +79.4% |
Valuation Metrics
Evenly matched — SANG and LPSN each lead in 1 of 2 comparable metrics.
Valuation Metrics
| Metric | ||
|---|---|---|
| Market CapShares × price | $139M | $32M |
| Enterprise ValueMkt cap + debt − cash | $182M | $329M |
| Trailing P/EPrice ÷ TTM EPS | -19.99x | -0.22x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | 2.96x | — |
| Price / SalesMarket cap ÷ Revenue | 0.42x | 0.13x |
| Price / BookPrice ÷ Book value/share | 0.55x | — |
| Price / FCFMarket cap ÷ FCF | 4.22x | — |
Profitability & Efficiency
SANG leads this category, winning 5 of 6 comparable metrics.
Profitability & Efficiency
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | -3.0% | — |
| ROA (TTM)Return on assets | -2.2% | -12.4% |
| ROICReturn on invested capital | -0.4% | -6.6% |
| ROCEReturn on capital employed | -0.6% | -5.8% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 5 |
| Debt / EquityFinancial leverage | 0.22x | — |
| Net DebtTotal debt minus cash | $43M | $297M |
| Cash & Equiv.Liquid assets | $13M | $95M |
| Total DebtShort + long-term debt | $56M | $392M |
| Interest CoverageEBIT ÷ Interest expense | -1.29x | 0.20x |
Total Returns (Dividends Reinvested)
SANG leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in SANG five years ago would be worth $12,507 today (with dividends reinvested), compared to $35 for LPSN. Over the past 12 months, SANG leads with a -27.5% total return vs LPSN's -77.1%. The 3-year compound annual growth rate (CAGR) favors SANG at 5.4% vs LPSN's -65.4% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -15.9% | -31.1% |
| 1-Year ReturnPast 12 months | -27.5% | -77.1% |
| 3-Year ReturnCumulative with dividends | +17.0% | -95.8% |
| 5-Year ReturnCumulative with dividends | +25.1% | -99.7% |
| 10-Year ReturnCumulative with dividends | +1995.0% | -97.0% |
| CAGR (3Y)Annualised 3-year return | +5.4% | -65.4% |
Risk & Volatility
SANG leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
SANG is the less volatile stock with a 0.16 beta — it tends to amplify market swings less than LPSN's 2.05 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. SANG currently trades 64.6% from its 52-week high vs LPSN's 12.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.16x | 2.05x |
| 52-Week HighHighest price in past year | $6.49 | $21.60 |
| 52-Week LowLowest price in past year | $3.63 | $2.37 |
| % of 52W HighCurrent price vs 52-week peak | +64.6% | +12.4% |
| RSI (14)Momentum oscillator 0–100 | 52.2 | 40.3 |
| Avg Volume (50D)Average daily shares traded | 4K | 148K |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | — |
| Price TargetConsensus 12-month target | — | — |
| # AnalystsCovering analysts | 1 | — |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | 4 | — |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | +2.0% | 0.0% |
SANG leads in 4 of 6 categories — strongest in Income & Cash Flow and Profitability & Efficiency. 1 category is tied.
SANG vs LPSN: Frequently Asked Questions
8 questions · data-driven answers · updated daily
01Is SANG or LPSN a better buy right now?
For growth investors, Sangoma Technologies Corporation (SANG) is the stronger pick with -0.
9% revenue growth year-over-year, versus -22. 0% for LivePerson, Inc. (LPSN). Analysts rate Sangoma Technologies Corporation (SANG) a "Buy" — based on 1 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — SANG or LPSN?
Over the past 5 years, Sangoma Technologies Corporation (SANG) delivered a total return of +25.
1%, compared to -99. 7% for LivePerson, Inc. (LPSN). Over 10 years, the gap is even starker: SANG returned +1995% versus LPSN's -97. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — SANG or LPSN?
By beta (market sensitivity over 5 years), Sangoma Technologies Corporation (SANG) is the lower-risk stock at 0.
16β versus LivePerson, Inc. 's 2. 05β — meaning LPSN is approximately 1211% more volatile than SANG relative to the S&P 500.
04Which is growing faster — SANG or LPSN?
By revenue growth (latest reported year), Sangoma Technologies Corporation (SANG) is pulling ahead at -0.
9% versus -22. 0% for LivePerson, Inc. (LPSN). On earnings-per-share growth, the picture is similar: LivePerson, Inc. grew EPS 45. 4% year-over-year, compared to 40. 5% for Sangoma Technologies Corporation. Over a 3-year CAGR, SANG leads at 5. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — SANG or LPSN?
Sangoma Technologies Corporation (SANG) is the more profitable company, earning -2.
1% net margin versus -27. 6% for LivePerson, Inc. — meaning it keeps -2. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: SANG leads at -0. 5% versus -9. 6% for LPSN. At the gross margin level — before operating expenses — LPSN leads at 62. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Which pays a better dividend — SANG or LPSN?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
07Is SANG or LPSN better for a retirement portfolio?
For long-horizon retirement investors, Sangoma Technologies Corporation (SANG) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
16), +1995% 10Y return). LivePerson, Inc. (LPSN) carries a higher beta of 2. 05 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (SANG: +1995%, LPSN: -97. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
08What are the main differences between SANG and LPSN?
Both stocks operate in the Technology sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.